Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Pfizer Inc (PFE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Pfizer's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
26.32 +0.06    +0.23%
23/04 - Closed. Currency in USD ( Disclaimer )
After Hours
26.33
+0.01
+0.04%
19:59:41 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 20,296,525
  • Bid/Ask: 26.32 / 26.33
  • Day's Range: 26.19 - 26.47
Pfizer 26.32 +0.06 +0.23%

NYSE:PFE Financials

 
A brief overview of the NYSE:PFE financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Pfizer over time.

Pfizer Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 1,910 million compared to USD 2,217 million a year ago. Revenue was USD 14,249 million compared to USD 24,290 million a year ago. Net loss was USD 3,369 million compared to net income of USD 4,995 million a year ago. Basic loss per share from continuing operations was USD 0.59 compared to basic earnings per share from continuing operations of USD 0.89 a year ago. Diluted loss per share from continuing operations was USD 0.59 compared to diluted earnings per share from continuing operations of USD 0.87 a year ago. Basic loss per share was USD 0.6 compared to basic earnings per share of USD 0.89 a year ago. Diluted loss per share was USD 0.6 compared to diluted earnings per share of USD 0.87 a year ago.For the full year, revenue was USD 58,496 million compared to USD 100,330 million a year ago. Net income was USD 2,119 million compared to USD 31,372 million a year ago. Basic earnings per share from continuing operations was USD 0.38 compared to USD 5.59 a year ago. Diluted earnings per share from continuing operations was USD 0.37 compared to USD 5.47 a year ago. Basic earnings per share was USD 0.38 compared to USD 5.59 a year ago. Diluted earnings per share was USD 0.37 compared to USD 5.47 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

PFE Income Statement

Gross margin TTM 58.99%
Operating margin TTM 8.99%
Net Profit margin TTM 3.62%
Return on Investment TTM 3.02%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Oct 01, 2023 Jul 02, 2023 Apr 02, 2023
Total Revenue 14249 13232 12734 18282
Gross Profit 1135 9927 9802 13535
Operating Income -7120 2954 2657 6662
Net Income -3369 -2382 2327 5543

PFE Balance Sheet

Quick Ratio MRQ 0.5
Current Ratio MRQ 0.91
LT Debt to Equity MRQ 69.44%
Total Debt to Equity MRQ 84.63%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Oct 01, 2023 Jul 02, 2023 Apr 02, 2023
Total Assets 226501 215021 220168 195617
Total Liabilities 137213 117817 120875 94381
Total Equity 89288 97204 99293 101236

PFE Cash Flow Statement

Cash Flow/Share TTM 1.54
Revenue/Share TTM 10.36
Operating Cash Flow  10.96%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Oct 01, 2023 Jul 02, 2023 Apr 02, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 5240 -1208 1212
Cash From Investing Activities -10996 -25485 3315
Cash From Financing Activities 5442 27174 -2771
Net Change in Cash -317 475 1754
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Kevin Parker
Kevin Parker Apr 09, 2024 7:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I appreciate what Pfizer does... But where are the cancer vaccines 9ther companies are developing?
Jay Clerk
Jay Clerk Apr 09, 2024 7:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They make more off treating it then treating the side effectswith more pills to treat the side effects from the pills and so on
Petru Zogo
Petru Zogo Apr 02, 2024 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pfizer is in Europe in the middle of a scandal of proportions together with the president Ursula from. EU because of the strange contracts made during the Covid19 epidemic
Joe McKela
Joe McKela Apr 02, 2024 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Corruption, bribery, blackmail, the regular big pharma MO.
ali can
ali can Mar 25, 2024 3:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
George Galloway
George Galloway Mar 22, 2024 4:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Leadership has to be removed to regain the trust of investors.
Joe McKela
Joe McKela Mar 22, 2024 4:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No, it is corrupt to its core and huge lawsuits will follow.
shortseller Best
shortseller Best Mar 19, 2024 8:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pfizer has 88,000 employees, but its stock price is low. Why? Some analysts say Pfizer will hit $45 a share, but I don't think that will happen unless the CEO steps down.
Faris Tubishat
Faris Tubishat Mar 19, 2024 8:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They have a new drug for cancer this will blow up the stock I think in this year to at least 36
Ward Spence
Ward Spence Mar 19, 2024 8:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Because of pending lawsuits
Péter Dovák
Péter Dovák Mar 12, 2024 9:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
30+ soon
George Galloway
George Galloway Mar 04, 2024 10:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sad to see a CEO drive a company in the ground and get pad so much money to do it.
Faris Tubishat
Faris Tubishat Mar 04, 2024 10:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will it go up analysis said it will reach 45
Vladimir Unknown
Vladimir Unknown Feb 16, 2024 4:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
6% dividends🤑, why short? Anyone can explain how i can loose money if buy now?
Joe McKela
Joe McKela Feb 13, 2024 5:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just the beginning, wait until the compensations start. It will be the end for this sh.....
Eric Ruiz
Eric Ruiz Feb 05, 2024 11:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Cramer says sell
Sofiya Litski
Sofiya Litski Feb 05, 2024 11:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
so we must buy
Aa Ro
Aa Ro Feb 05, 2024 11:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Cramer is mostly wrong
Brian Chong
Brian Chong Feb 05, 2024 11:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
if Cramer says sell, then I'm buying
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email